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Summary
This article presents a novel formulation for preparation of Lactobacillus casei 01 encap-
sulated in soy protein isolate and alginate microparticles using spray drying method. A 
response surface methodology was used to optimise the formulation and the central com-
posite face-centered design was applied to study the effects of critical material attributes 
and process parameters on viability of the probiotic after microencapsulation and in simu-
lated gastrointestinal conditions. Spherical microparticles were produced in high yield (64 
%), narrow size distribution (d50=9.7 μm, span=0.47) and favourable mucoadhesive proper-
ties, with viability of the probiotic of 11.67, 10.05, 9.47 and 9.20 log CFU/g after microen-
capsulation, 3 h in simulated gastric and intestinal conditions and four-month cold stor-
age, respectively. Fourier-transform infrared spectroscopy confirmed the probiotic stability 
after microencapsulation, while differential scanning calorimetry and thermogravimetry 
pointed to high thermal stability of the soy protein isolate-alginate microparticles with en-
capsulated probiotic. These favourable properties of the probiotic microparticles make 
them suitable for incorporation into functional food or pharmaceutical products.
Key words: Lactobacillus casei 01, alginate, soy protein isolate, microparticles, spray drying, 
formulation optimisation
______________________________
*Corresponding author: Phone: +389 70 384 648; Fax: +389 23 123 054; E-mail: krml@ff.ukim.edu.mk 
ORCiD IDs: 0000-0003-3879-7409 (Hadzieva), 0000-0003-2503-4699 (Mladenovska), 0000-0002-1927-7101 (Simonoska Crcarevska), 
0000-0002-7008-9149 (Glavaš Dodov), 0000-0003-3192-9472 (Dimchevska), 0000-0002-2073-5632 (Geškovski), 0000-0002-6343-8216 
(Grozdanov), 0000-0002-6673-0917 (Popovski), 0000-0002-9493-0457 (Petruševski), 0000-0001-6817-7556 (Chachorovska), 0000-0002-4237-
4073 (Petreska Ivanovska), 0000-0003-3952-4226 (Petruševska-Tozi), 0000-0002-6240-2481 (Ugarkovic), 0000-0002-8101-6359 (Goracinova)
174 J. HADZIEVA et al.: L. casei Encapsulated in SPI-Alginate Microparticles, Food Technol. Biotechnol. 55 (2) 173–186 (2017)
Introduction
The modern lifestyle and consequences of unhealthy 
eating habits on the one hand, and the strong evidence of 
health benefits gained by probiotic consumption on the 
other have stimulated the food and pharmaceutical in-
dustry to produce novel probiotic ingredients and prod-
ucts, with estimated market share of approx. 36.7 billion 
dollars by 2018 (1). The probiotics have been found to be 
effective for a large number of gut disorders and for im-
proving/maintaining the oral and urogenital health (2–4). 
Other studies have indicated protective cardiovascular ef-
fects and promising effects in cancer, brain, obesity, aller-
gy and atopic diseases, and in combatting diseases where 
dysbiosis has been observed (5–9). However, providing 
and maintaining the required minimum of viable probi-
otic cells to exert health effects (107 CFU/g at a point of 
delivery) is a great challenge, considering their sensitivity 
to processing, storage and administration. Microencapsu-
lation could be applied as an effective method for achiev-
ing these goals (10). Among many microencapsulation 
techniques, spray drying is one of the most challenging 
due to low costs, industrial application, high probiotic 
stability in the product and preserved cellular integrity 
during drying, when both process and formulation para-
meters are optimised correctly. So far, alginate was most ly 
used as a protective polymeric matrix for probiotic micro-
encapsulation, producing a particularly strong molecular 
framework and thermoirreversible and freeze-thaw stable 
microparticles in the presence of Ca2+ (11). However, the 
Ca-alginate beads alone have shown low ability to protect 
the cells at a low pH due to the sensitivity of Ca2+/COO– 
linkage to Ca2+-chelating agents in the gastrointestinal 
tract (GIT) (12). For this reason, complexation of alginate 
with other polymers has been commonly used to control 
the disintegration of alginate beads and to target the pro-
biotic release within the GIT, although with variable suc-
cess (11,13).
In search for novel microparticulated probiotic for-
mulation that can provide high viability of Lactobacillus 
casei 01 and that can dictate its release in the small intes-
tine (pH≥6.8), we have prepared several formulations in 
which alginate was combined with other polymers such 
as whey protein (14,15) and chitosan (16). Lactobacillus ca-
sei 01 was chosen based on its previously confirmed effects 
in colon inflammation (15) and increased blood pressure 
(17). In addition, in vivo and in vitro evidence confirms the 
L. casei role in the improvement of lactose tolerance (18) 
and suppression of tumour growth by modulating non-
specific immune responses (19). However, as other probi-
otics, L. casei 01 is easily degraded during production and 
storage of the final products, or when orally adminis-
tered, as was previously confirmed (14,16). In order to 
overcome the disadvantages of the previously used meth-
ods for microencapsulation, such as difficulties in scale-up 
and high costs of the emulsion method (14), and signifi-
cant probiotic viability loss when spray drying method 
was combined with freeze drying (16), in this study, an 
attempt was made to achieve high viability of L. casei 01 
during processing, storage and digestion by its encapsu-
lation in alginate and soy protein isolate (SPI) microparti-
cles using spray drying only. The SPI was chosen due to 
its confirmed nutritional and health benefits, availability, 
biodegradability, low immunogenicity and similarity with 
the components of the tissue extracellular matrix (20,21). 
It can be easily processed and linked to other biocompati-
ble polymers, giving materials with enhanced mechanical 
properties. It was expected of the cell cross-linked SPI-al-
ginate microparticles to protect the probiotic from the 
harsh processing and in vivo conditions. The additional 
aim of the study was to find out whether this protection is 
sufficient to provide the required probiotic viability or 
whether enhancement in the mechanical stability of SPI-
alginate microparticles by ionic cross-linking is required. 
For this reason, L. casei 01 was encapsulated both in Ca2+ 
cross-linked and non- -cross-linked SPI-alginate micro-
particles. The critical formulation and process factors af-
fecting significantly the viability of L. casei 01 after spray 
drying and in simulated GIT conditions were identified 
and, based on the obtained results and established corre-
lations between the variables of interest, a subsequent op-
timisation of the formulation and microencapsulation 
process was performed. In addition, the physicochemical 
and biological properties of the optimal formulation of 
probiotic microparticles were determined. To our knowl-
edge, this is the first time the probiotic cells have been en-
capsulated in microparticles prepared with SPI-alginate 
and for that aim, spray drying technique was used.
Materials and Methods
Materials
FD-DVS nu-trish® Lactobacillus casei 01, a freeze-dried 
probiotic culture from Chr. Hansen, Copenhagen, Den-
mark, was used as a bacterial strain. Commercial soy pro-
tein isolate (SPI) was purchased from Sojaprotein a.d. 
Bečej (Bečej, Serbia), whereas alginate (Protanal® LF 10/60 
LS sodium alginate, guluronic acid content 35–45 %) was 
kindly donated by FMC Biopolymer UK Ltd. (Girvan, 
UK). Calcium chloride, MRS (de Man, Rogosa, Sharpe) agar 
and broth, and peptone water were purchased from Mer-
ck KGaA (Darmstadt, Germany). Bile salts (ox gall) were 
supplied from Sigma-Aldrich (Poole, UK), while pepsin 
from porcine gastric mucosa (800–2500 U/mg) and pan-
creatin (>100 U/mg) from porcine pancreas were from 
Sigma-Aldrich (St. Louis, MO, USA). All reagents and 
laboratory equipment were autoclaved before usage.
Preparation of L. casei 01 encapsulated in SPI-alginate 
microparticles
Preparation of the probiotic for microencapsulation
For microencapsulation, the probiotic cells were acti-
vated in 5 mL of MRS broth at 37 °C for 24 h under aero-
bic conditions, as previously described (14,16). Afterwards, 
the cells were harvested by centrifugation at 1500×g for 10 
min and washed twice with sterile 0.1 % (by mass per vol-
ume) peptone water.
Preparation of microparticles
The SPI-alginate microparticles with encapsulated L. 
casei 01 were prepared by spray drying method. In detail, 
aqueous mixture of alginate and SPI (pH=7.0) was inocu-
lated with 1 % (by mass per volume) bacterial suspension 
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(cell load approx. 12 log CFU/g) and homogenised by stir-
ring on a magnetic stirrer (600 rpm, model 4803-02; Cole- 
-Palmer, Vernon Hills, IL, USA) at room temperature for 
30 min. The resultant mixture kept under low speed agi-
tation on a magnetic stirrer (200 rpm) was infused into a 
spray drying nozzle (model Mini Spray Dryer B-290; 
Büchi Labortechnik AG, Flawil, Switzerland) and contin-
uously sprayed using an automatic infusion/withdrawal 
pump (model 6530R096 3.1 A/ph 9407; Sonceboz SA, Son-
ceboz-Sombeval, Switzerland). The conditions of the spray 
drying process were: nozzle diameter 0.7 mm, aspirator 
pressure 90 %, atomizer pressure 600 nL/h and flow rate 5 
mL/min. As stipulated by the experimental design, series 
of cross-linked SPI-alginate microparticles with encapsu-
lated probiotic were prepared by introduction of the pro-
biotic microparticles collected from the cyclone into aque-
ous solution of CaCl2, followed by continuous stirring 
(800 rpm) at room temperature for 1 h. Thus obtained mi-
croparticles were removed from the solution of CaCl2 by 
centrifugation (1000×g, 5 min, Centric 322B centrifuge; Te-
htnica, Železniki, Slovenia), washed three times with ster-
ile water, frozen at –20 °C and freeze dried at 7 Pa and –50 
°C for 24 h (FreeZone 2.5 Liter Benchtop Freeze Dry Sys-
tem; Labconco Corp., Kansas City, MO, USA).
Experimental design study – process and formulation 
optimisation
The critical material attributes (type and concentra-
tion of alginate, SPI and CaCl2) and process parameters 
(inlet temperature (IT)) were identified varying one pa-
rameter at a time. In order to characterise the influence of 
the determined critical variables and, subsequently, to 
find their optimal values for the production of SPI-algi-
nate microparticles with encapsulated L. casei 01, response 
surface methodology based on central composite face- 
-centered design of experiments was used. The concentra-
tions of alginate (A), SPI (B) and CaCl2 (C), and IT (D) ap-
plied for preparation of the probiotic microparticles were 
systematically varied in given ranges and the probiotic vi-
ability after microencapsulation and testing in simulated 
gastrointestinal (GI) conditions (pH=1.5 after 3 h and pH= 
6.8 after 3 h) was determined as the response of interest. 
Probiotic viability in both CFU per g of microparticles 
and in percentage of viable cells from the initial cell count 
was determined in order to evaluate the number of viable 
cells after microencapsulation and in simulated GI condi-
tions, as well as the efficacy of the encapsulation process. 
The process and formulation parameters were represent-
ed by their coded and actual values.
Physicochemical characterisation of L. casei 01  
encapsulated in SPI-alginate microparticles
Encapsulation efficacy
The encapsulation efficacy (EE/%), i.e. the percentage 
of bacterial cells that survived the process and was encap-
sulated inside the microparticles was calculated as fol-
lows:
 EE=(N/N0)·100 /1/
where N0 is the number of viable bacteria in CFU per g of 
culture and N is the number of viable bacteria in CFU per 
g of microparticles.
Particle size analysis
The size distribution of the optimised microparticles 
was determined using laser diffraction particle size ana-
lyser (Mastersizer 2000, equipped with Hydro 2000S/G; 
Malvern Instruments Ltd., Worcestershire, UK) in the wet 
dispersions. The wet dispersions were prepared by dis-
persing the particles (15–20 mg) in 2 mL of 2 % (by mass) 
solution of Polysorbate® 80 (Sigma-Aldrich, Poole, UK), in 
an ultrasonic bath (Ultrawave Limited, Cardiff, UK) for 
10 min. A small aliquot of the resulting suspension was 
transferred to the measurement cell containing the blank 
dispersing medium (distilled water). The measurements 
were performed under stirring (2520 rpm) and ultra-
sound (50 % duty cycle), previously applied for 5 min. 
The obscuration was set between 10 and 12 %. At least six 
measurements were done. The particle diameter was de-
termined, and particle size distribution was expressed in 
terms of span factor:
 Span=(d90–d10)/d50 /2/
where d90, d10 and d50 are the diameter sizes and the num-
bers in subscript indicate the percentage of particles 
smaller than that size (span<2 indicates a narrow size dis-
tribution).
Morphological analysis
The morphology of the microparticles in the different 
phases of preparation was observed using a scanning 
electron microscope (SEM JSM-5300; JEOL Ltd., Tokyo, 
Japan). Microparticle samples were attached to an adhe-
sive tape and coated with gold by sputter coater (SEM 
JFC-1100E ion sputter; JEOL Ltd.).
Moisture content
The moisture content of the optimised probiotic mi-
croparticles was calculated by two methods: infrared mois-
 ture measurement method, where 2 g of sample were placed 
in an aluminium pan and dried at 105 °C for 24 h (Mettler 
Toledo AG, Greifensee, Switzerland), and Karl Fischer meth-
od, with one-component system using HydranalTM-Com-
posite 5 (model V20S Compact Volumetric KF Titrator; 
Mettler-Toledo, Columbus, OH, USA) as a titrating solu-
tion (22). The experiments were carried out in triplicates 
and the average value was taken as a result.
Humidity
The humidity of the optimised probiotic microparti-
cles was determined by drying to constant mass of 5 g of 
powder for 3 h at 105 °C. The heated sample was cooled 
in a desiccator and weighed. The procedure was repeated 
until a constant mass was obtained. The humidity was 
calculated by the following equation (23):
 Humidity=(5/constant mass)–1 /3/
Solubility
The solubility of the optimal formulation was deter-
mined by dissolving 1 g of sample in 100 mL of distilled 
water, homogenised at room temperature, then collected 
by centrifugation (1500×g, 15 min, Centric 322B centri-
fuge; Tehtnica) and dried in an oven (model 7802; Sutjes-
ka Beograd, Belgrade, Serbia) at 75 °C for 5 h. The solubil-
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ity percentage was calculated from the difference between 
the initial mass of microparticles and the mass obtained 
after solubilisation (23).
Wettability
To evaluate the ability of the solid surface to absorb 
moisture when in contact with water, 2 g of microparti-
cles (optimal formulation) were placed in 400 mL of wa-
ter. The time required for all the particles to become moist 
was evaluated visually (23).
Storage test
The optimised microparticles of L. casei 01 were stored 
in penicillin tubes that were hermetically sealed and placed 
in a desiccator. Probiotic survival was evaluated by count-
ing the viable cells after 1 and 4 months of storage at 4 °C. 
The experiments were performed in triplicates.
Fourier-transform infrared study
Fourier-transform infrared (FTIR) spectroscopy (Per kin-
Elmer 2000 FTIR; Waltham, MA, USA) was used to deter-
mine the interactions between the probiotic and polymers, 
and the stability of L. casei 01 during microencapsulation, 
as previously described (14,16). The FTIR-attenuated total 
reflection (FTIR-ATR) spectra were recorded at room tem-
perature by Specac®Golden Gate ATR Mk II with ZnSe 
lenses (Specac Ltd., Orpington, UK). The characteristic ab-
sorption bands of the polymers and the probiotic were 
recorded in a frequency range of 4000–400 cm–1 for the 
following samples (2 mg of homogenised sample or 100 
μL of dispersion): pure alginate and SPI, their physical 
mixture, L. casei 01, physical mixture of alginate, SPI and 
L. casei 01, and blank and microparticles with encapsulat-
ed L. casei 01. The molecular changes of the probiotic 
structure during the microencapsulation process were ex-
amined by comparing the spectra of non-encapsulated 
probiotic and L. casei 01 released from the microparticles.
Thermal property study
The thermal properties of the samples were studied 
by thermogravimetry (TG) and differential scanning ca-
lorimetry (DSC). The TG thermograms of pure alginate 
and SPI, their physical mixture, physical mixture of algi-
nate, SPI and L. casei 01, and blank and loaded microparti-
cles (7–10 mg per sample) were recorded by a thermo-
gravimetric analyser (model Pyris 1 TGA; PerkinElmer, 
Shelton, CT, USA), in a temperature range of 30–900 °C, at 
a heating rate of 10 °C/min. DSC study was carried out in 
a differential scanning calorimeter (model DSC 204 F1 
Phoenix®, Netzsch-Gerätebau GmbH, Selb, Germany), at 
a heating rate of 10 °C/min up to 300 °C. The investiga-
tions were done under nitrogen atmosphere.
Biological characterisation of L. casei 01 encapsulated 
in SPI-alginate microparticles
Swelling studies
The swelling behaviour of the optimal formulation of 
microparticles was determined in the simulated GI fluids 
by exchanging the intestinal juices (24). Namely, after 
each treatment in the adequate medium, the microparti-
cles were collected by centrifugation, washed once with 
distilled water and placed in the next medium. Certain 
amount of microparticles was consequently suspended in 
5 mL of simulated gastric juice (SGJ; 0.08 mol/L of HCl, 
pH=1.5) and simulated intestinal juice (SIJ; 0.05 mol/L of 
KH2PO4, pH=6.8) for 3 h. Samples of microparticles were 
taken from the gastric fluid after 0.5 and 3 h, and from the 
intestinal fluid, with pH=6.8, after 0.5 and 3 h. The ad-
sorbed water on the surface of the microparticles was im-
mediately removed with filter paper and the particle size 
distribution was measured by laser diffraction particle 
size analyser (Mastersizer 2000, equipped with Hydro 
2000S/G; Malvern Instruments Ltd.). The percentage of 
swelling was calculated according to:
 Swelling=[(dt–d0)/d0]·100 /4/
where dt and d0 are the mean volume diameters of the mi-
croparticles at time t and in the dry state, respectively.
Enumeration of Lactobacillus casei 01
The viability of L. casei 01 alone and encapsulated in 
the SPI-alginate microparticles was assessed after dissolu-
tion of 1 g of probiotic cells and 1 g of microparticles in 9 
g of phosphate buffer saline (1 mol/L, pH=7.0), using the 
plate count method as previously described (14,16). The 
cell counts were determined by sequential dilutions using 
0.1 % (by mass per volume) peptone water to achieve 
countable cell numbers. Quantitative determination of vi-
able cells was performed in triplicate on selective MRS 
agar after incubation for 72 h at 37 °C under aerobic con-
ditions, counting the plates with 30–250 colonies. The av-
erage results were expressed in CFU per g of sample.
Viability of free and encapsulated L. casei 01 in 
simulated gastrointestinal conditions
The viability of L. casei 01 encapsulated in the SPI-al-
ginate microparticles was determined in the simulated GI 
fluids by exchanging the intestinal juices (24). Addition-
ally, the viability of L. casei 01 in the optimised microparti-
cles was compared with the viability of non-encapsulated 
probiotic under the same conditions. In detail, the probi-
otic cells alone (1:10 by volume, cell load approx. 12 log 
CFU/g) or microencapsulated (1:10 by mass per volume) 
were incubated in the SGJ (0.08 mol/L of HCl with 0.2 %, 
by mass per volume, NaCl and 0.3 %, by mass per vol-
ume, pepsin, pH=1.5) at 37 °C for 3 h in a horizontal shak-
er (75 rpm, model SWB 20; Haake, Waltham, MA, USA). 
Consequently, the separated and washed probiotic cells 
and microparticles were transferred (1:9 by mass per vol-
ume) into the SIJ with pH=6.8 (0.05 mol/L of KH2PO4 with 
1 %, by mass per volume, bile salts (ox gall) and 1 %, by 
mass per volume, pancreatin) and pH=7.4 (0.05 mol/L of 
KH2PO4), respectively, and incubated for additional 3 and 
4 h, respectively, under the same conditions. Samples 
were taken after 0.5 h and at the end of the incubation pe-
riod from the SGJ (pH=1.5) and SIJ (pH=6.8) and after 2 
and 4 h from the SIJ (pH=7.4), and the viability of L. casei 
01 was determined with the already described enumera-
tion method.
Adhesive properties of L. casei 01 encapsulated in 
SPI-alginate microparticles
The adherence capacity of L. casei 01 alone and encap-
sulated in the optimised SPI-alginate microparticles was 
tested in vitro. Pig mucin was mixed with cells (1:4, by 
volume) or microparticles (1:4, by mass per volume) and 
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incubated in different buffer solutions (pH=2.0, 4.5, 6.8 
and 7.4) (25) at 37 °C. After 1, 3, 5 and 24 h of incubation, 
the samples were centrifuged (1500×g, 10 min, model 
Centric 322B; Tehtnica) and the remaining free pig mucin 
in the supernatants was measured by UV/Vis spectropho-
tometer (model Lambda 16; PerkinElmer) at 251 nm. The 
binding efficiency of cells or microparticles was calculat-
ed using the following equation:
 Binding efficiency of pig mucine=[(c0–cs)/c0]·100 /5/
where c0 is the initial concentration of pig mucine used for 
incubation, and cs is the concentration of free pig mucin 
determined in the supernatant.
Statistical analysis
Design-Expert® trial v. 8 software was used for the 
design of experiments (Stat-Ease, Inc., Minneapolis, MN, 
USA). One-way ANOVA for the fitted model for all re-
sponses of interest was applied. Values of p<0.05 indicat-
ed that the model terms were significant. The predicted 
and adjusted R2 within 0.2 of each other and adequate 
precision values greater than 4 suggested that the models 
can be used for navigation in the designed space. The 
paired t-test was used for comparison of viability and ad-
hesive properties of L. casei 01 and probiotic microparti-
cles (Microsoft Excel®, Microsoft Corp. Redmond, WA, 
USA). Differences were considered statistically significant 
at p<0.05.
Results and Discussion
Preparation and optimisation of probiotic encapsulated 
in microparticles
A total of 30 experiments were designed and carried 
out at random to optimise the process and formulation 
for the microencapsulation of the probiotic. The equa-
tions describing the mathematical correlation between the 
followed responses and the studied factors were estab-
lished based on the obtained results for the responses of 
interest (Table 1). The negative sign in front of the factors 
indicates inverse relation between the response of interest 
and the studied factors, while vice versa applies for the 
positive sign.
The viability of L. casei 01 in the designed formula-
tions after preparation procedure was in a range of 8.86–
11.77 log CFU/g, or expressed in percentage of the initial 
cell count in the formulation for preparation of micropar-
ticles, 74 to 98 %. The influence of the examined variables 
on these response values was described by a linear model 
expressed in log CFU/g (Eq. 6) and percentage values (Eq. 
7), respectively:




where A, B, C and D represent alginate, SPI, CaCl2 and IT, 
respectively.
With the increase in the alginate concentration, the 
viability/encapsulation efficacy of the probiotic increased, 
while the opposite effect was observed when the concen-
trations of cross-linking agent, soy protein isolate and IT 
increased. One-way ANOVA indicated that the formula-
tion parameter C was a significant model term for both 
response values.   
The viability of L. casei 01 in SGJ (pH=1.5) after 3 h 
was in the range of 3.00–11.54 log CFU/g or expressed in 
percentage of the initial cell count in the microparticles 
after preparation, from 27 to 98 %. The reduced quadratic 
model was used to describe the relation between the pro-
biotic viability in SGJ and studied factors (Eq. 8 for viabil-
ity in log CFU/g and Eq. 9 for viability in percentage):
 N(viable cells)2.35/(log CFU/g)=+116.03+ 




where A, B and C represent alginate, SPI, CaCl2 and IT, 
respectively.
One-way ANOVA indicated that the variables C and 
C2 (results expressed in log CFU/g; Fig. 1a) and C (results 
expressed in percentage; Fig. 1b) should be considered as 
statistically significant. With the increase in the concen-
tration of Ca2+ in the cross-linking solution, the viability of 
L. casei 01 significantly decreased.
The viability of the probiotic after 3 h in SIJ (pH=6.8) 
was in the range of 3.00–10.20 log CFU/g or from 29 to 89 
% of the initial cell count entering the SGJ. The reduced 
cubic model was used for description of the relations be-
tween these response values and studied factors (Eqs. 10 




where A, B, C and D represent alginate, SPI, CaCl2 and IT, 
respectively.
Individial variables A, C, A2 and interactions between 
A and C, B and D, and B, C and D (results expressed in 
log CFU/g; Fig. 1c) and individual variables A, C, A2 and 
interactions between A and C, A, B and D, and B, C and D 
(results expressed in percentage; Fig. 1d) were indicated 
as significant model terms.
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According to the ANOVA results for the fitted models 
for all responses, the predicted and the adjusted R2 were 
within 0.2 of each other, while adequate precision values 
were greater than 6, thus signifying satisfactory model fit. 
The derived correlations enabled optimisation of the for-
mulation by means of maximisation of all responses. The 
optimal batches with the predicted responses were identi-
fied and they are presented in Table 2. The cross-valida-
tion of the model, confirmation report and the percentage 
of relative error of the predicted and experimental values 
pointed to the optimal IT for spray drying (132 °C) and 
the optimal formulation for preparation of microparticles 
(4 and 1 %, by mass of alginate and soy protein isolate, 
respectively), which preserve probiotic viability above the 
required minimum under all conditions. Insignificant dif-
ferences of 0.27, 0.04 and 1.06 log CFU/g between the pre-
dicted and obtained viabilities were observed when the 
viability tests of the probiotic encapsulated in the opti-
mised microparticles after their preparation and place-
ment in the SGJ and SIJ (data presented below) were per-
formed, indicating acceptable relative errors of approx. 
2.37, –0.39 and 12.60 %, respectively (Table 2).
The major drawback of the spray drying method for 
probiotic microencapsulation is the limited survival of the 
probiotics due to the mechanical stress and heat treat-
ment involved (26). This can explain the opposite effect of 
IT on L. casei 01 viability. However, the number of reports 
Table 1. Coded values of studied variables and obtained responses for designed formulations of soy protein isolate-alginate mic-










20 1 0 1 0 0   9.60 80.00 4.32 45.00 4.07 42.40
24 2 0 0 0 1 10.07 83.92 4.37 43.40 3.30 32.78
13 3 –1 –1 1 1 10.37 86.42 5.00 48.22 3.00 28.93
23 4 0 0 0 –1 11.39 94.92 3.00 26.34 4.00 35.12
25 5 0 0 0 0 11.00 91.67 9.10 82.73 3.23 29.36
19 6 0 –1 0 0 11.28 94.00 3.00 26.60 4.00 35.46
27 7 0 0 0 0   9.63 80.25 8.43 87.54 4.00 41.54
16 8 1 1 1 1 10.18 84.83 8.60 84.50 3.00 29.47
4 9 1 1 –1 –1 11.47 95.58 10.47 91.28 6.20 54.05
21 10 0 0 –1 0 10.00 83.33 8.70 87.00 5.34 53.40
22 11 0 0 1 0 10.24 85.33 5.47 53.42 3.00 29.30
11 12 –1 1 –1 1 11.77 98.08 11.54 98.05 9.75 82.84
8 13 1 1 1 –1 10.69 89.08 9.30 87.00 7.02 65.67
18 14 1 0 0 0   9.57 79.75 9.30 97.19 5.84 61.02
2 15 1 –1 –1 –1 11.69 97.42 9.95 85.12 8.47 72.46
28 16 0 0 0 0 11.22 93.46 8.74 77.96 3.47 30.94
10 17 1 –1 –1 1 11.47 95.58 10.31 89.89 9.44 82.30
26 18 0 0 0 0 11.00 91.67 9.00 81.82 3.00 27.27
1 19 –1 –1 –1 –1 11.75 97.92 10.79 91.83 8.62 73.36
29 20 0 0 0 0 11.40 95.00 9.20 80.70 3.30 28.95
6 21 1 –1 1 –1 10.87 90.58 5.00 46.00 3.70 34.04
17 22 –1 0 0 0 10.82 90.17 5.47 50.55 5.00 46.21
30 23 0 0 0 0 10.98 91.50 9.70 88.34 4.28 38.98
9 24 –1 –1 –1 1 10.25 85.42 9.88 96.39 9.30 90.74
3 25 –1 1 –1 –1 11.68 97.29 9.50 81.37 7.60 65.10
14 26 1 –1 1 1 11.47 95.58 10.56 92.07 10.20 88.93
5 27 –1 –1 1 –1 10.72 89.33 4.91 45.80 3.11 29.01
15 28 –1 1 1 1   8.86 73.79 5.77 65.16 3.00 33.88
12 29 1 1 –1 1 11.00 91.67 10.04 91.27 9.76 88.73
7 30 –1 1 1 –1 10.35 86.25 7.00 67.63 3.69 35.65
Coded values –1 and +1 for A (alginate) and B (soy protein isolate) correspond to actual values of 1 and 4 % (by mass), respectively, for 




















































































































































Fig. 1. Dependence of the viability of Lactobacillus casei 01 en-
capsulated in optimised soy protein-alginate microparticles on 
the mass fractions of CaCl2 and alginate (ALG) at inlet tempera-
ture of 132 °C and 1 % (by mass) of soy protein isolate. The via-
bility is expressed in percentage of the initial cell count and in 
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addressing this issue is limited and they are usually relat-
ed to the amount and type of coating materials, pointing 
out that the viability of encapsulated bacteria increases in 
direct proportion to the amount of coating material, 
which temporarily reduces the heat transfer into the cells 
(27). Similar results were observed in a previous study, 
where L. casei 01 was exposed to high IT of 120 °C during 
microencapsulation in chitosan-coated alginate micropar-
ticles prepared by spray drying (16). The highest amounts 
of coating materials were used to obtain microparticles 
with favourable physicochemical properties and accepta-
ble probiotic viability, but at the expense of encapsulation 
efficiency, suggesting that a balanced ratio of materials is 
essential to provide functional groups available for bind-
ing bacterial cells.
The ability of cells to bind alginate chains and form 
network structure has been widely explored in cell and 
tissue engineering (28,29). Alginate is not cell interactive 
and hence, when the cells are added to non-modified algi-
nate solutions in the absence of chemical cross-linker, the 
cell-cell interactions dominate, leading to cell aggregation 
and creation of non-homogeneous gel network. However, 
in the presence of adhesion ligand-modified alginate, 
they generate homogeneous cross-linked network owing 
to specific receptor-ligand interactions. There is a great 
possibility that the soy protein isolate serves as a cell ad-
hesion ligand (and signalling molecule for cell prolifera-
tion), considering its potential for steric and electrostatic 
interactions and short range forces such as van der Waals, 
acid-base, hydrogen bonding and biospecific interactions 
with both alginate and cells (30). Additionally, the cross- 
-linking segments of alginate by soy protein isolate can 
change the conformation of alginate and increase the local 
charge density, thus promoting adsorption of soy protein 
isolate and probiotic cells. The same was observed when a 
well-known adhesive ligand arginine-glycine-aspartic acid 
(RGD) was conjugated to the alginate backbone (31). When 
fibroblast cells were added to the RGD-modified alginate 
solution without the use of calcium, a larger number of 
cells were mobilised due to the more available bonds be-
tween the cells and cell-interactive polymers. In addition, 
several extracellular matrix proteins have also been cou-
pled with alginate to promote cell attachment (e.g. colla-
gen), as was reviewed by Bidarra et al. (32). This can ex-
plain why the increase in the alginate concentration and 
by that increased content of soy protein isolate provided 
higher probiotic viability after microencapsulation and 
the opposite effect of CaCl2 was observed. The effect on 
probiotic viability of freeze-drying process, used to im-
prove the shelf stability and handling properties of micro-
particles cross-linked with Ca2+, cannot be excluded. De-
spite the ability of Ca2+ in the alginate system to protect 
the cell envelopes and secondary proteins of the probiot-
ics after freeze-drying (33), this effect was probably hin-
dered by the detrimental effect of freeze-drying on the 
constituents of the cell wall due to the ice crystal forma-
tion. This was evident for several probiotics when micro-
encapsulation and freeze-drying were combined (34,35).
One of the biggest concerns in using the cell-cross- 
-linked microparticles for preserving the viability of L. ca-
sei 01 in the GIJ was their mechanical strength. Therefore, 
for the cross-linking density to be increased, series of mi-
croparticles cross-linked with Ca2+ were prepared. A strong-
er molecular framework of Ca-alginate, formed by coop-
erative binding of Ca2+ with the aligned polyguluronate 
ribbons and partial covalent bonds between Ca2+ and oxy-
gen atom of C-O-C groups of alginate (33), was expected 
to compensate for viability loss during freeze-drying and 
provide higher probiotic viability in low pH and control-
led release at pH≥6.8. This expectation was supported by 
a previous study that pointed to significant improvement 
of the L. casei 01 stability/viability in the SGJ and SIJ with 
the increase in CaCl2 concentration, when chitosan-coated 
alginate microparticles were additionally cross-linked with 
Ca2+ (16).
On the contrary, with the increase in the concentra-
tion of the cross-linking agent, the probiotic viability at 
pH=1.5 decreased and this effect was evident in both re-
sponse values expressed in CFU/g and in percentage of 
viable cells from the initial cell count entering the SGJ. 
The opposite effect was observed when the concentra-
tions of alginate and soy protein isolate increased, sug-
gesting that the compact network of the soy protein iso-
late-alginate microparticles with encapsulated probiotic 
is able to preserve the probiotic viability in acidic media 
effectively and thus provide high cell count at pH≥6.8. 
There is a possibility that the higher concentration of 
CaCl2 in the cross-linking medium competitively dis-
placed the soy protein from its bonding site with alginate, 
leading to the formation of microparticles with more 
junction zones and/or increased porosity. If so, the probi-
otic exposure to the harsh SGJ conditions as well as the 
susceptibility of the microparticles to disintegration was 
increased (12). Therefore, the higher adhesion capacity 
and possibly the lower vulnerability of the cell-cross- 
-linked SPI-alginate microparticles to the environmental 
stress (acidic pH, bile salts and digestive enzymes) could 
explain the higher probiotic viability in the simulated GIJ. 
Similar were the findings of Smilkov et al. (14), where the 
viability of L. casei 01 in the SGJ and SIJ was positively 
(dominantly) affected by the concentration of whey pro-
tein when incorporated in Ca2+-cross-linked whey pro-
tein-alginate microparticles, with the effect of alginate 
and Ca2+ being insignificant. In addition, there is a possi-
bility that the stability of the SPI-alginate complex was 
additionally increased by the thermal denaturation of the 
SPI during spray drying due to increased number of hy-
drophobic interactions, hydrogen bonding and structure 
folding that cause irreversible changes in the functional 
properties of the complex. This was confirmed in a study 
of Rajam et al. (36) when L. plantarum MTCC 5422 was mi-
cro encapsulated in undenatured and denatured whey pro -
tein isolate with alginate using spray drying and freeze - 
-drying techniques, respectively. Cells entrapped in the 
denatured whey protein isolate were more stable in simu-
lated acidic and bile acid conditions than those entrapped 
in the undenatured protein.
Physicochemical properties of L. casei 01 encapsulated 
in SPI-alginate microparticles
The optimised SPI-alginate microparticles with en-
capsulated probiotic were easily recovered from the 
spray-dryer, showing no tendency to stick to the spray 
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drying chamber and cyclone. They were produced in rel-
atively high yield ((63.8±1.7) %), with d50 =(9.7±0.5) μm and 
very narrow size distribution (span=0.47). The particle 
size distribution corresponded to the data reported in the 
literature (10–20 μm) for probiotic microparticles ob-
tained by spray drying (26,27,36).
The SEM micrographs of L. casei 01 (as obtained from 
the producer) and of blank and microparticles containing 
the probiotic are shown in Fig. 2. As the images show, the 
blank and the microparticles with the probiotic have simi-
lar morphology and tendency to agglomerate. Spherical 
but also flattened disk-shaped particles are presented, 
which is the usual appearance of the microparticles pre-
pared by spray drying. The surface appears wrinkled 
with scarcely visible porosity.
The probiotic encapsulated in the microparticles pro-
duced using optimal formulation showed low level of hu-
mi dity, (0.8±0.1) %, solubility of approx. (95.0±0.2) % and 
acceptable wettability of 100 % in 5 min. These data are 
similar to the ones of maltodextrin microparticles with 
encapsulated L. casei 01 obtained by spray drying (23), 
confirming that soluble complexes are formed in mixed 
solutions with anionic polysaccharide in excess, as was 
previously suggested by Xiao et al. (37) as well. The water 
content in the microparticles was (8.1±0.2) %, not exceed-
ing 10 %, which is suggested as maximum for the stability 
of microencapsulated probiotics during storage (38). The 
viability of the microencapsulated L. casei 01 during 4- 
-month storage at 4 °C remained higher than the required 
minimum ((9.20±0.03) log CFU/g, approx. 82 % preserved 
viability).
The stability of L. casei 01 during microencapsulation 
was evaluated by rough assignment of the corrected FT-
IR-ATR spectra of the probiotic released from the micro-
particles and non-encapsulated one. Generally, the FTIR- 
-ATR spectrum of L. casei 01 before encapsulation was 
comparable to the spectra reported for other lactic acid 
bacteria, identified by the FTIR fingerprint method (39, 
40). As in previous studies, in which emulsion and spray 
drying were used for microencapsulation, the spectra of 
non-encapsulated and L. casei 01 released from the SPI-al-
ginate microparticles were almost identical, with an ad-
ditional band at 1127 cm–1 in the spectrum of released cells 
relevant for lactic acid (14,16).
Fig. 2. Scanning electron microscope images of: a) Lactobacillus casei 01, b) blank soy protein isolate-alginate microparticles, and c and 
d) soy protein isolate-alginate microparticles with encapsulated L. casei 01
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The FTIR-ATR spectrum of alginate used for micro-
encapsulation has been previously investigated (14,16). 
The spectrum obtained in this work is presented in Fig. 3, 
spectrum a. Generally, the spectrum of SPI (Fig. 3, spec-
trum b) corresponded to the spectrum already described 
in the literature (41). Amide I (from the C=O group within 
the peptide bond) occurred at 1633 cm–1, amide II (from 
the coupled vibrations of ν(C-N) and δ(О-Н)) at 1529 cm–1, 
while the band at around 3277 cm–1 corresponds to the 
ν(N-H) vibrations (wide signal due to the hydrogen 
bonds). The region 3110–3000 cm–1 is associated with the 
aromatic valent ν(C-H) vibrations originating from the 
aromatic amino acids in the SPI, while at 2990–1850 cm–1, 
the aliphatic ν(C-H) vibrations are assigned. In the spec-
tra of the physical mixtures (Fig. 3, spectra d and e), the 
characteristic spectrum of SPI dominated, plus an inten-
sive band at around 1025 cm–1, characteristic for skeletal 
vibrations of C-C and C-O of alginate. The same was also 
observed in the FTIR-ATR spectra of samples with differ-
ent SPI to alginate ratio (1:4 to 4:1; data not shown), sug-
gesting no interactions between the polymers, and 
between the polymers and the probiotic.
In the spectra of the blank and microparticles with 
encapsulated probiotic (Fig. 3, spectra f and g, respective-
ly), the characteristic bands of alginate dominated. In ad-
dition, bands of amide I (at 1632 cm–1 in the SPI) and of 
valence vibrations of –COOH (at 1596 cm–1 in alginate) 
overlapped, and the characteristic band of amide II origi-
nating from the SPI at around 1528 cm–1 was observed. All 
these spectral data associated with the complex content of 
the probiotic and SPI suggest that hydrogen bonds as 
well as electrostatic and hydrophobic interactions be-
tween the polymers and the probiotic exist. The complex-
ity of SPI used in the study was previously confirmed 
with sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (data not shown). The presence of proteins with 
molecular mass below 113 kDa was detected, dominantly 
21 and 35 kDa, and protein sub-domain in a range of 53–
100 kDa. This is in accordance with the literature data 
pointing that the principal polypeptides of glycinin can 
be detected in a range between 20 and 29 kDa, while the 
principal protein subunits of α-conglycinin are between 
56 and 97 kDa (42). Due to the complexity and possibly 
the low content of the probiotic in the microparticles, the 
spectral data of the encapsulated probiotic were not clear-
ly identified in the spectrum of microparticles. However, 
the spectral characteristics of L. casei 01 released from the 
SPI-alginate microparticles pointed to preserved structur-
al stability and fermentative activity, which was also ob-
served in previous studies (14,16).
The FTIR-ATR findings were consistent with the ther-
mal stability studies. Characteristic thermal curves of the 
studied samples obtained by differential scanning calo-
rimetry and thermogravimetric analysis are shown in 
Figs. 4 and 5, respectively, while the characteristic param-
a














































Fig. 3. FTIR-ATR spectra of alginate (ALG; a), soy protein iso-
late (SPI; b), Lactobacillus casei 01 (c), physical mixture of ALG 
and SPI at 4:1 (d), physical mixture of ALG, SPI and L. casei 01 
at 4:1:0.05 (e), blank SPI-alginate microparticles (f), and L. casei 
01 encapsulated in SPI-alginate microparticles (g)
Fig. 4. Differential scanning calorimetry of alginate (ALG; a), 
soy protein isolate (SPI; b), Lactobacillus casei 01 (c), physical mix-
ture of ALG and SPI at 4:1 (d), physical mixture of ALG, SPI and 
L. casei 01 at 4:1:0.05 (e), blank SPI-alginate microparticles (f), 
and L. casei 01 encapsulated in SPI-alginate microparticles (g)
Fig. 5. Thermogravimetric analysis of soy protein isolate (SPI; 
a), mixture of alginate and SPI at 4:1 (b), physical mixture of al-
ginate, SPI and Lactobacillus casei 01 at 4:1:0.05 (c), blank SPI-al-
ginate microparticles (d), and L. casei 01 encapsulated in SPI-al-
ginate microparticles (e). Note: Starting from 300 °C alginate is 
subjected to thermal degradation, hence its thermogram is ex-
cluded from the figure
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eters determined from the obtained thermograms are 
shown in Table 3. According to the obtained results, the 
blank and SPI-alginate microparticles with the probiotic 
were characterised by similar values of the glass transi-
tion temperature (tg) (60–70 °C) compared to the neat 
polymers and their corresponding physical mixtures (Fig. 
4 and Table 3). According to the TG thermograms, in all 
samples initial mass loss of approx. 2–4 % was observed, 
corresponding to the water desorption at temperature 
(td0) between 47–60 °C (Table 3 and Fig. 5). The TG ther-
mograms of neat alginate (sample I in Table 3) and SPI 
(sample II in Table 3 and curve a in Fig. 5) showed one- 
-step degradation at a temperature (td1) of 209.0 and 249.4 
°C, respectively, unlike those of the physical mixtures, 
which showed three-step degradation (samples IV and V 
in Table 3 and curves b and c in Fig. 5). For the polymers 
and their physical mixtures (including the one with L. ca-
sei 01) intensive degradation started above 200 °C. Con-
sidering the microparticles, the TG thermograms of both 
blank (sample VI in Table 3 and curve d in Fig. 5) and mi-
croparticles with encapsulated probiotic (sample VII in 
Table 3 and curve e in Fig. 5) showed similar mass loss 
and higher thermal stability than the neat alginate and 
SPI, with initial dehydration starting at 250 °C, followed 
by two overlapping processes in the first derivative of TG 
curve (DTG) and final degradation at around 600 °C. The 
higher decomposition temperature of the microparticles 
with encapsulated probiotic confirms the existing interac-
tions between the polymers (and the probiotic) in the mic-
roparticles. The higher thermal stability of the micropar-
ticles might be due to the lower chance for elimination of 
small molecules like CO2 and CO, with the formation of 
electrostatic bonds between the positively charged amine 
and negatively charged carboxylic groups of soy protein 
isolate and alginate, respectively.
Biological properties of SPI-alginate microparticles 
with encapsulated L. casei 01
In accordance with the solubility and wettability data 
for the microparticles, negligible change in d50 from the 
initial value was observed after 0.5 h in pH=1.5 (approx. 
10 % increase) when the swelling studies were performed. 
However, after 3 h in the same SGJ, a tenfold increase in 
the particle size was detected (d50=111 μm vs. 9.7 μm at 
zero time point) and maximum swelling was obtained. 
When the microparticles were subsequently placed in the 
SIJ (pH=6.8), the structure began to loosen and the mic-
roparticles to disintegrate. Such a swelling behaviour was 
expected, considering the sensitivity of the microparticle 
structure to the swelling medium pH and susceptibility of 
the soy protein isolate to cell/enzyme proteolytic activity. 
At pH=1.5, all negatively charged groups are neutralised 
and there are fewer positive amine than carboxyl groups. 
As a result, the electrostatic repulsion is lower and the 
polymer chain relaxation increases to be comparable with 
the medium diffusion, resulting in slower swelling. How-
ever, at pH=6.8, the polymer chain relaxation is reduced 
because of electrostatic repulsion among negative charg-
es, so that the medium diffusion is faster than the relax-
ation of the polymer chains, pointing to diffusion-con-
trolled swelling (43,44).
The probiotic release profile was consistent with the 
swelling behaviour of the SPI-alginate microparticles with 
encapsulated probiotic, suggesting that the probiotic re-
lease is governed by a combination of diffusion, dissolu-
tion and degradation processes. After 3 h at pH=1.5, an 
insignificant loss of viability was observed, approx. 14 % 
(Table 2). In SIJ (pH=6.8), after 3 h, approx. 81 % of the 
initial number of viable cells (9.45 log CFU/g) entering the 
SGJ were preserved, while after 4 h at pH=7.4, approx. 67 
% of the initial viable cells (7.82 log CFU/g) encapsulated 
in the microparticles formed under optimal conditions 
survived the simulated GI passage. At the same time, the 
viability of the free non-encapsulated probiotic cells was 
significantly reduced, by approx. 50 %, and additional 24 
% after 0.5 and 3 h in SGJ (pH=1.5), respectively.
Besides viability, for the probiotics to exert their ben-
eficial effect by the proved mechanisms (interference with 
the adherence of pathogens to the intestinal mucosal cells, 
immunomodulation, stimulation of epithelial cell prolif-
eration and differentiation and fortification of the intesti-
nal barrier), they should permanently colonise the human 
intestinal tract (45). Bacteria adhere to GI surfaces by non-
-specific physical interactions, promoted by the protein 
and carbohydrate constituents of the bacterial cells (46, 
47). Therefore, it is reasonable that a probiotic with potent 
Table 3. Characteristic temperatures of neat polymers, their physical mixtures, blank and soy protein isolate-alginate microparticles 
with encapsulated Lactobacillus casei 01
Sample tg/°C td0/°C DTG0/°C td1/°C DTG1/°C td2/°C DTG2/°C td3/°C DTG3/°C
I 70.0 n.d. n.d. 209.0 n.d. n.d. n.d. n.d. n.d.
II 60.0 51.0 64.1 249.4 306.8 n.d. n.d. n.d. n.d.
III n.d. n.d. n.d. 292.8 n.d. 336.4 n.d. n.d. n.d.
IV 68.0 54.2 79.2 211.2 218.5 315.7 304.0 670.1 756.0
V 61.0 46.6 64.2 208.3 217.0 283.8 301.0 689.8 728.0
VI 63.0 46.0 67.7 225.7 248.1 307.0 334.1 640.6 695.1
VII 66.0 59.9 77.2 227.4 250.4 n.d. n.d. 656.3 691.0
I=alginate, II=soy protein isolate, III=Lactobacillus casei 01, IV=physical mixture of alginate and soy protein isolate (4:1), V=physical 
mixture of alginate, soy protein isolate and L. casei 01 (4:1:0.05), VI=blank soy protein-alginate microparticles, VII=soy protein-alginate 
microparticles with encapsulated L. casei 01, tg=glass transition temperature, td0=temperature of water desorption, td1–3=temperatures of 
thermal degradation, DTG=first derivative of TG curve, n.d.=not determined
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intestinal mucosal cell adhesion properties be used and/
or probiotic carrier exhibit prolonged residence time in 
the lower intestine. In this regard, the binding of pig mu-
cin to probiotic cells and optimised microparticles in me-
dia with different pH values was also evaluated.
Specifically, after 5 h in all buffer media, the binding 
efficacy of pig mucin on probiotic cells alone did not ex-
ceed 18 % and it was significantly lower than the one of 
the microparticles with the encapsulated probiotic (109–
143 % difference) (Fig. 6). The reason for such a binding 
capacity can be the repulsion between the negatively 
charged probiotic used in the actual study (16) and nega-
tively charged mucin. Under similar pH conditions, low 
adherence capacity of mucin to other probiotics was de-
tected as well (Bifidobacterium 5 %, Lactobacillus rhamnosus 
GG 10 %, B. lactis Bb12 18 % and B. animalis 31 %) (48). 
After 5 h of incubation, the lowest binding efficacy of pig 
mucin on the microparticles in the medium with pH=2 
(approx. 42 %) was measured, while at pH=4.5, 6.8 and 
7.4, it increased to approx. 45, 57 and 61 %, respectively. 
These data can be explained by the forces involved in the 
process of mucin-polymer adhesion. Most of the litera-
ture data report of the improvement in adhesion of micro-
encapsulated probiotics based on alginate coating; how-
ever, the mucoadhesion can significantly increase when 
alginate is blended with mucoadhesive polymers (49). 
When the carboxylate groups of alginate are exposed to 
the acidic environment of the SGJ, they become protonat-
ed and hence, their bonding with mucin glycoproteins 
through carboxyl-hydroxyl interactions are reduced. 
However, the interactions between the microparticles and 
mucin in the soy protein isolate are stronger due to the 
protonation of NH3+ ions and their interaction with the 
functional groups of the mucin. With the increase in the 
pH, the carboxylate groups of alginate become deproton-
ated, allowing the formation of hydrogen bonds with the 
hydrogen part of the mucus layer, thus increasing the 
mucoadhesivity. The same happens with the free carboxy-
late groups of SPI. Therefore, the enhanced mucoadhesion 
and thus, site-specific delivery and prolonged clearance 
time of optimised cross-linked SPI-alginate microparticles 
containing probiotic may be dominantly attributed to soy 
protein isolate, i.e. its functional hydroxyl, amino and thi-
ol groups.
Conclusion
This study presents a simple method for encapsula-
tion of the probiotic Lactobacillus casei 01 in soy protein 
isolate-alginate microparticles by spray drying. The opti-
misation of the process and formulation parameters re-
sulted in the production of novel probiotic microparticles 
with preserved stability and viability of the probiotic 
above the minimum level of 107 CFU/g at point of deliv-
ery, after microencapsulation and in simulated gastroin-
testinal juice, and high potential for targeted release of 
probiotic and prolonged residence in the small intestine. 
In addition, microparticles with acceptable physicochem-
ical properties for further incorporation into food or phar-
maceutical products were prepared.
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Fig. 6. Binding efficacy of pig mucin to Lactobacillus casei 01 and 
L. casei 01 encapsulated in soy protein-alginate microparticles 
(SPI-ALG MPs) at pH: a) 2, b) 4.5, c) 6.8 and d) 7.4. Bars repre-
sent standard deviation
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